As 2024 kicks off, we’re taking a moment to reflect on an incredible journey in 2023. Last year was marked by  hashtag#growth ,  hashtag#innovation  and laying the foundations for future  hashtag#impact : Closed our investment round: Our oversubscribed investment round totalled £2M, combining support from  Parkwalk ,  SFC Capital ,  Oxford Innovation  and  Innovate UK Grew our team to 8 people: The amazing OSSTEC team combines experience from previous founders, surgeons, orth

OSSTEC had an amazing time exhibiting at International Society for Technology in Arthroplasty (ISTA), New York, in September. It was a pleasure to unveil our first product to surgeons and industry. Some key highlights include podium presentations from our team demonstrating research at OSSTEC and surgical usability sessions trialling our devices.

We're thrilled to share that OSSTEC has been nominated for Best SEIS Investee Company of 2023! This recognition highlights our team's dedication to delivering impact and innovation in   hashtag#medtech . We're honoured to be acknowledged among the best in the S/EIS community. Our CEO,   Maxwell Munford, PhD , has also been nominated for   hashtag#Entrepreneur   of the Year! Special thanks to our amazing team, partners and investors for their support. Stay tuned as we eagerly

OSSTEC is honored to announce nominations for three prestigious awards by the UK Business Angels Association and EISA. Our gratitude extends to the Royal Academy of Engineering and Innovate UK for their sponsorship. These nominations underscore our team's dedication to technological innovation.

OSSTEC successfully closes an oversubscribed £1.2M funding round, bolstering our journey from lab to operating room with our 3D printing and biomimetic implants. This boost empowers team growth and tech development. Immense gratitude to our investors and supporters, including SFC, Parkwalk Advisors, and Embryo Ventures.